Skip to main content

Clinical Trials Using Carboplatin

Review the clinical trials studying carboplatin on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 176-200 of 266

Reduced Dose Chemotherapy in Combination with Immunotherapy for the Treatment of Stage IV Non-small Cell Lung Cancer in Vulnerable or Older Adults with a PD-L1 Tumor Proportion Score < 50%
Status: Active
Location: VCU Massey Comprehensive Cancer Center, Richmond, Virginia
Chemotherapy with or without HCW9218 before Surgery for the Treatment of Stage III-IV High Grade Serous Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy before Surgery for the Treatment of Patients with Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients with High-Risk Neuroblastoma
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Dual Immune Strategy (Nivolumab and Ipilimumab) versus Single Checkpoint Blockade (Pembrolizumab) in Combination with Chemotherapy for the Treatment of PD-L1 Negative Stage IV Non-small Cell Lung Cancer, DISCERN Trial
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Lamivudine in Combination with Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Pembrolizumab after Radiation Therapy and Chemotherapy in Treating Patients with Limited Stage Small Cell Lung Cancer
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Evaluation of Immune Cells and Response-Adapted Chemoimmunotherapy before Surgery for the Treatment of Triple-Negative Breast Cancer, The NeoTRACT Trial
Status: Active
Location: University of Kansas Hospital-Westwood Cancer Center, Westwood, Kansas
Anthracycline-Free Chemotherapy and Immunotherapy Regimen for the Treatment of Triple-Negative Breast Cancer Patients at Risk for Cardiotoxicity, NeoCARD Trial
Status: Active
Location: Medical University of South Carolina, Charleston, South Carolina
Volrustomig Priming Regimens Exploratory Phase II Platform Study
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Tiragolumab and Atezolizumab for the Treatment Newly Diagnosed PD-L1 Positive Resectable Stage III-IV Oral Cavity Squamous Cell Carcinoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Pembrolizumab in Combination with Chemotherapy for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma, SINERGY Study
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Entrectinib for the Treatment of Patients Less Than 3 Years of Age with NTRK1/2/3 or ROS1 Fused High Grade Glioma or Other Central Nervous System Tumor
Status: Active
Location: Saint Jude Children's Research Hospital, Memphis, Tennessee
Neoadjuvant Toripalimab in Combination with Chemotherapy followed by Transoral Robotic Surgery or Risk and Response-based Chemotherapy and/or Radiation for the Treatment of Locoregional HPV16+ Oropharyngeal Squamous Cell Cancer, TARGET HPV Cohort 2 Trial
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsies for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Status: Active
Location: University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
Carboplatin, Paclitaxel, and Pembrolizumab Before Surgery Followed by Olaparib and Pembrolizumab with or without Bevacizumab for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Tafasitamab and Lenalidomide followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients with Relapsed/ Refractory Large B-Cell Lymphoma
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Propranolol and Chemoradiation Therapy for the Treatment of Patients with Esophageal Cancer
Status: Active
Location: Roswell Park Cancer Institute, Buffalo, New York
Circulating Tumor DNA Monitoring for Treatment Response Prediction and Treatment Reduction after Surgery in Patients with Stage IB, II, and IIIB Non-small Cell Lung Cancer, DNA-PREDICT Trial
Status: Active
Location: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida
Carboplatin and Cabazitaxel versus Lutetium-177-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, CATCH-177 Trial
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Chemotherapy and Cemiplimab with or without Alirocumab before Surgery for the Treatment of Lung Cancer in Patients with Stage IB-IIIA Non-small Cell Lung Cancer
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
High Dose Radiation Therapy with Pembrolizumab and Chemotherapy for the Treatment of Patients with PD-L1 Positive Metastatic Triple Negative Breast Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia